TGF-β and cancer

This publication has 195 references indexed in Scilit:

• TGF-β: A Critical Modulator of Immune Cell Function
  Clinical Immunology and Immunopathology, 1997
• Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a
  Cell, 1997
• Intracellular signalling: The Mad way to do it
  Current Biology, 1996
• The somatic mutation frequency of the transforming growth factor β receptor type II gene varies widely among different cancers with microsatellite instability
  European Journal of Surgical Oncology, 1996
• Mutations of the Transforming Growth Factor-β Type II Receptor Gene and Genomic Instability in Hereditary Nonpolyposis Colorectal Cancer
  Biochemical and Biophysical Research Communications, 1995
• The Royal Marsden Hospital pilot tamoxifen chemoprevention trial
  Breast Cancer Research and Treatment, 1994
• Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
  Journal of Clinical Investigation, 1993
• Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease
  Nature, 1992
• Transforming growth factor beta1 in ductal carcinoma in situ and invasive carcinomas of the breast
  European Journal Of Cancer, 1992
• Growth factor involvement in the multihormonal regulation of MCF-7 breast cancer cell growth in soft agar
  Breast Cancer Research and Treatment, 1991